|
1
|
Tanuma J, Shisa H, Hiai H, et al:
Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced
tongue carcinogenesis in the rat. Cancer Res. 58:1660–1664.
1998.PubMed/NCBI
|
|
2
|
Tanuma J, Fujii K, Hirano M, et al: Five
quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced
tongue cancer in the rat. Jpn J Cancer Res. 92:610–616. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kitano M, Hatano H and Shisa H: Strain
difference of susceptibility to 4-nitroquinoline 1-oxide-induced
tongue carcinoma in rats. Jpn J Cancer Res. 83:843–850. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kitano M, Hirayama Y, Tanuma J, et al:
Genetic controls of susceptibility and resistance to
4-nitroquinoline 1-oxide-induced tongue carcinomas in rats. Jpn J
Cancer Res. 87:1097–1101. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kwitek AE, Gullings-Handley J, Yu J, et
al: High-density rat radiation hybrid maps containing over 24,000
SSLPs, genes, and ESTs provide a direct link to the rat genome
sequence. Genome Res. 14:750–757. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
RGD-Rat Genome Database. http://rgd.mcw.edu/. May
1, 2011
|
|
7
|
Tanuma J, Hirano M, Hirayama Y, et al:
Genetic predisposition to 4NQO-induced tongue carcinogenesis in the
rat. Med Princ Pract. 14:297–305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirano M, Tanuma J, Hirayama Y, et al: A
speed congenic rat strain bearing the tongue cancer susceptibility
locus Tscc1 from Dark-Agouti rats. Cancer Lett. 231:185–191.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
NBRP. The National BioResource Project for
the Rat in Japan. NBRP Rat No. 0268http://www.nbrp.jp/.
Aug 10, 2010
|
|
10
|
Liu H, Higashi K and Hiai H: Role of
resistant Drh1 locus in chemical carcinogen-induced
hepatocarcinogenesis in rats: analysis with a speed congenic
strain. Cancer Sci. 96:164–169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Walentinsson A and Levan G: Ras
gene mutations in 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat
sarcomas. Cancer Lett. 166:47–53. 2001. View Article : Google Scholar
|
|
12
|
Tanuma J, Hiai H, Shisa H, et al:
Carcinogenesis modifier loci in rat tongue are subject to frequent
loss of heterozygosity. Int J Cancer. 102:638–642. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ogawa K, Tanuma J, Hirano M, et al:
Selective loss of resistant alleles at
p15INK4B and
p16INK4A genes in chemically-induced rat
tongue cancers. Oral Oncol. 42:710–717. 2006.PubMed/NCBI
|
|
14
|
Manenti G, Peissel B, Gariboldi M, et al:
A cancer modifier role for parathyroid hormone-related protein.
Oncogene. 19:5324–5328. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benelli R, Peissel B, Manenti G, et al:
Allele-specific patterns of the mouse parathyroid hormone-related
protein: influences on cell adhesion and migration. Oncogene.
22:7711–7715. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Krishnan VG, Mort ME, et al:
Automated inference of molecular mechanisms of disease from amino
acid substitutions. Bioinformatics. 25:2744–2750. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomas PD, Campbell MJ, Kejariwal A, et
al: PANTHER: a library of protein families and subfamilies indexed
by function. Genome Res. 213:2129–2141. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Capriotti E, Calabrese R and Casadio R:
Predicting the insurgence of human genetic diseases associated to
single point protein mutations with support vector machines and
evolutionary information. Bioinformatics. 22:2729–2734. 2006.
View Article : Google Scholar
|
|
19
|
Bromberg Y and Rost B: SNAP: predict
effect of non-synonymous polymorphisms on function. Nucleic Acids
Res. 35:3823–3835. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Adzhubei IA, Schmidt S, Peshkin L, et al:
A method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ng PC and Henikoff S: Predicting
deleterious amino acid substitutions. Genome Res. 11:863–874. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cartharius K, Frech K, Grote K, et al:
Matlnspector and beyond: promoter analysis based on transcription
factor binding sites. Bioinformatics. 21:2933–2942. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schug J: Using TESS to transcription
factor binding sites in DNA sequence. Curr Protec Bioinfomatics.
21:2.6.1–2.6.15. 2008.
|
|
24
|
Laboratory animal data. Japan SLC Inc;
2007, http://jslc.co.jp. Feb 2,
2011
|
|
25
|
Fukunaga M, Eto S and Saito S:
Multicentric clinical studies on measurement of carboxyl-terminal
parathyroid hormone-related protein in normal subjects (the first
report). Clin Endocrinol. 40:977–986. 1992.
|
|
26
|
Takeda T, Sugihara K, Hirayama Y, et al:
Immunohistological evaluation of Ki-67, p63, CK19 and p53
expression in oral epithelial dysplasias. J Oral Pathol Med.
35:369–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dittmer J: The importance of PTHrP for
cancer development. Gene Ther Mol Biol. 8:451–464. 2004.
|
|
28
|
Goltzman D, Karaplis AC, Kremer R and
Rabbani SA: Molecular basis of the spectrum of skeletal
complications of neoplasia. Cancer. 88(Suppl 12): 2903–2908. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Käkönen SM and Mundy GR: Mechanisms of
osteolytic bone metastases in breast carcinoma. Cancer. 97(Suppl
3): 834–839. 2003.PubMed/NCBI
|
|
30
|
Mannstadt M, Jüppner H and Gardella TJ:
Receptors for PTH and PTHrP: their biological importance and
functional properties. Am J Physiol. 277:F665–F675. 1999.PubMed/NCBI
|
|
31
|
Maioli E and Fortino V: The complexity of
parathyroid hormone-related protein signaling. Cell Mol Life Sci.
61:257–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cataisson C, Lieberherr M, Cros M, et al:
Parathyroid hormone-related peptide stimulates proliferation of
highly tumorigenic human SV40-immortalized breast epithelial cells.
J Bone Miner Res. 15:2129–2139. 2000. View Article : Google Scholar
|
|
33
|
Henderson JE, Amizuka N, Warshawsky H, et
al: Nucleolar localization of parathyroid hormone-related peptide
enhances survival of chondrocytes under conditions that promote
apoptotic cell death. Mol Cell Biol. 15:4064–4075. 1995.
|
|
34
|
Lam MH, House CM, Tiganis T, et al:
Phosphorylation at the cyclin-dependent kinases site
(Thr85) of parathyroid hormone-related protein
negatively regulates its nuclear localization. J Biol Chem.
274:18559–18566. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Conlan LA, Martin TJ and Gillespie MT: The
COOH-terminus of parathyroid hormone-related protein (PTHrP)
interacts with β-arrestin 1B. FEBS Lett. 527:71–75. 2002.PubMed/NCBI
|
|
36
|
Ferrari SL, Behar V, Chorev M, et al:
Endocytosis of ligand-human parathyroid hormone receptor 1
complexes is protein kinase C-dependent and involves β-arrestin2.
Real-time monitoring by fluorescence microscopy. J Biol Chem.
274:29968–29975. 1999.PubMed/NCBI
|
|
37
|
Fiaschi-Taesch N, Takane KK, Masters S, et
al: Parathyroid-hormone-related protein as a regulator of pRb and
the cell cycle in arterial smooth muscle. Circulation. 110:177–185.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shiina H, Igawa M, Breault J, et al: The
human T-cell factor-4 gene splicing isoforms, Wnt signal pathway,
and apoptosis in renal cell carcinoma. Clin Cancer Res.
9:2121–2132. 2003.PubMed/NCBI
|
|
39
|
Scibetta AG, Santangelo S, Coleman J, et
al: Functional analysis of the transcription repressor
PLU-1/JARID1B. Mol Cell Biol. 27:7220–7235. 2007. View Article : Google Scholar : PubMed/NCBI
|
